Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C16H20N2O4 |
| Molecular Weight | 304.341 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=C(CN(O)C(N)=O)C2=C(C)C3(CC3)[C@@](C)(O)C(=O)C2=C1
InChI
InChIKey=VWMPVAZEBAKLFR-HNNXBMFYSA-N
InChI=1S/C16H20N2O4/c1-8-6-10-12(11(8)7-18(22)14(17)20)9(2)16(4-5-16)15(3,21)13(10)19/h6,21-22H,4-5,7H2,1-3H3,(H2,17,20)/t15-/m0/s1
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
833721
Created by
admin on Wed Apr 02 12:25:40 GMT 2025 , Edited by admin on Wed Apr 02 12:25:40 GMT 2025
|
||
|
FDA ORPHAN DRUG |
832821
Created by
admin on Wed Apr 02 12:25:40 GMT 2025 , Edited by admin on Wed Apr 02 12:25:40 GMT 2025
|
||
|
FDA ORPHAN DRUG |
850721
Created by
admin on Wed Apr 02 12:25:40 GMT 2025 , Edited by admin on Wed Apr 02 12:25:40 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
L683VC69K8
Created by
admin on Wed Apr 02 12:25:40 GMT 2025 , Edited by admin on Wed Apr 02 12:25:40 GMT 2025
|
PRIMARY | |||
|
924835-67-6
Created by
admin on Wed Apr 02 12:25:40 GMT 2025 , Edited by admin on Wed Apr 02 12:25:40 GMT 2025
|
PRIMARY | |||
|
15945880
Created by
admin on Wed Apr 02 12:25:40 GMT 2025 , Edited by admin on Wed Apr 02 12:25:40 GMT 2025
|
PRIMARY | |||
|
C203657
Created by
admin on Wed Apr 02 12:25:40 GMT 2025 , Edited by admin on Wed Apr 02 12:25:40 GMT 2025
|
PRIMARY |
ACTIVE MOIETY